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Vasc Endovasc Surg 2008;36:522-9.
Objective: The study aimed to define early clinical outcomes, and
medium term morphological changes, following endovascular treatment of
acute (AAD) and chronic (CAD) Type B aortic dissections.
Main outcomes: The cohort comprised 78 patients who underwent
endovascular repair for AAD (38) and CAD (40). Early and late clinical
outcomes were prospectively recorded. All patients underwent serial follow
up with CT scanning. False lumen thrombosis rates, true, false and total
aortic short axis diameter were recorded at the mid point of the endograft
and below this level in the thoracic aorta. The total maximum aortic
diameter in the thoracic, abdominal aorta was quantified.
Results: The 30-d mortality was 2.6% in AAD and 7.5% in CAD.
The 30-d stroke and paraplegia rates were 5.3% and 0% in AAD. There
were no cases of stroke or paraplegia in patients with CAD. At 30 months
follow up, the cumulative survival for the two groups was 93% for AAD
and 66.5% for CAD (P  0.015, Kaplan Meier) and the cumulative
re-intervention rate was 62% and 55% in AAD and CAD respectively
(P  0.961, Kaplan-Meier). False lumen thrombosis rates were equiva-
lent in the two groups and were higher at the level of the endograft than
below this level (P  0.05). Aortic remodelling was greater in AAD,
whereas the aortic dimensions after treatment of CAD remained rela-
tively static. Up to 20% of patients in both groups demonstrated enlarge-
ment of the thoracic aorta.
Conclusions: The data support the use of endovascular repair of the
thoracic aorta in Type B aortic dissection. 30-d outcomes are acceptable.
Patients with AAD demonstrate significant aortic remodelling whereas
patients with CAD do not. This has significant implications for practice as
patients with CAD must rely on maintenance of false lumen thrombosis to
preserve the integrity of the endovascular repair.
Outcomes of Endovascular Repair of Acute Thoracic Aortic Injury:
Interrogation of the New Zealand Thoracic Aortic Stent Database (NZ
TAS)
Day C.P., Buckenham T.M. Eur J Vasc Endovasc Surg 2008;36:530-4.
Objectives: Report the New Zealand national experience of endovas-
cular repair of acute traumatic thoracic aortic injuries (TTAIs).
Design:Retrospective analysis of the NewZealand thoracic aortic stent
database between December 2001 and December 2007.
Materials and methods: Of the 134 patients on the database, 27
patients (20%) underwent endovascular repair of TTAI. Data collected
included age, sex, cause of injury, details of the procedure, complications
and mortality.
Results: Most patients were young, median age 20 (15–78), male
(n 19, 70%), and involved inmotor vehicle accidents (n 23, 85%).Median
length of aorta stented was 117 mm (77–200 mm). Great vessel origins were
covered intentionally in 23 (85%) patients, four (17%) requiring a hybrid
procedure. Average procedure time was 98.3 min (35–180). Primary technical
success was 96%, secondary technical success 100%. Endoleaks were observed in
four (15%) patients, one requiring a second endovascular procedure. There
were no conversions toopen surgery. Procedure-related complications occurred
in four (15%) patients. No patient developed cord injury. All cause mortality at
30 days is one (4%) and at discharge is two (7%) due to associated poly-trauma.
Conclusion: Our results add further evidence of the safety of endovas-
cular repair of thoracic aortic injury and compare favourably with those of
other centres.
A Systematic Review and Meta-analysis of Endovascular Repair
(EVAR) for Ruptured Abdominal Aortic Aneurysm
Rayt H.S., Sutton A.J., London N.J.M., Sayers R.D., BownM.J. Eur J Vasc
Endovasc Surg 2008;36:536-44.
Background: Endovascular abdominal aortic aneurysm (EVAR) repair
has become a well-established technique in the treatment of elective abdom-
inal aortic aneurysms (AAAs) due to proven benefits in mortality, hospital
stay and operation time compared to open repair. The aim of this study was
to estimate the mortality rate from EVAR due to ruptured abdominal aortic
aneurysm (RAAA).Methods and materials: A systematic review and meta-analysis of all
English language literature with information on mortality rates from EVAR
for RAAA was conducted.
Results: The pooled mortality rate from RAAA after EVAR across 31
studies concerning 982 patients was 24% (95% confidence interval (CI)
20–28%). The pooledmorbidity from 21 studies was 44% (95%CI 33–55%).
The average procedure time was 155.1 min, with an intra-operative blood
loss of 523 ml and hospital stay of 10.1 days. There is evidence of publication
bias suggesting the mortality rate may be under-estimated.
Conclusions: Mortality from EVAR for RAAA appears to be lower
than that which is reported for open repair of RAAA. However, the high
level of publication bias cannot be ignored and may actually indicate higher
mortality rates.
Deep Venous Thrombosis after Arterial Surgery a Literature Review
Bani-Hani M., Titi M., Al-khaffaf H. Eur J Vasc Endovasc Surg 2008;36:
565-73.
Objective: To quantify the risk of DVT in arterial surgery, and to assess
the need for prophylaxis.
Methods: A search was carried out through Medline, Embase and
Cochrane databases to identify published studies on DVT in arterial surgery.
To quantify the risk of DVT both randomised and prospective non-random-
ised studies were included for analysis. However, to assess the need for
prophylaxis only randomised controlled trials were considered.
Results: Twenty three prospective studies that evaluated DVT in
arterial surgery were identified. Ten reported data about DVT in aortic
surgery, seven studies evaluated DVT in general vascular surgery, three
studied DVT in infra-inguinal vascular surgery and three studied DVT
incidence in patients after limb amputations.
Conclusion: There is a wide variation in the reported incidence of
DVT in arterial surgery (2%–24%). This is mostly due to the diversity of
screening methods used and the inclusion or exclusion of below knee
DVT.
There is insufficient evidence to make a valid conclusion regarding the
routine use of anticoagulants prophylaxis in arterial surgery. However, until
such evidence becomes available, DVT prophylaxis in patients undergoing
arterial surgery will continue to be guided by evidence gained from studies of
general surgical patients.
Further Validation of the Peripheral Artery Questionnaire: Results
from a Peripheral Vascular Surgery Survey in the Netherlands
Smolderen K.G., Hoeks S.E., Aquarius A.E., Scholte op Reimer W.J.,
Spertus J.A., van Urk H., Denollet J., Poldermans D. Eur J Vasc Endovasc
Surg 2008;36:582-91.
Objectives: Peripheral arterial disease (PAD) is associated with adverse
cardiovascular events and can significantly impair patients’ health status.
Recently, marked methodological improvements in the measurement of
PAD patients’ health status have been made. The Peripheral Artery Ques-
tionnaire (PAQ) was specifically developed for this purpose. We validated a
Dutch version of the PAQ in a large sample of PAD patients.
Design: Cross-sectional study.
Methods: The Dutch PAQ was completed by 465 PAD patients (70%
men, mean age 65  10 years) participating in the Euro Heart Survey
Programme. Principal components analysis and reliability analyses were
performed. Convergent validity was documented by comparing the PAQ
with EQ-5D scales.
Results: Three factors were discerned; Physical Function, Perceived
Disability, and Treatment Satisfaction (factor loadings between 0.50
and 0.90). Cronbach’s  values were excellent (mean   0.94). Shared
variance of the PAQ domains with EQ-5D scales ranged from 3 to
50%.
Conclusions: The Dutch PAQ proved to have good measurement
qualities; assessment of Physical Function, Perceived Disability, and Treat-
ment Satisfaction facilitates the monitoring of patients’ perceived health in
clinical research and practice. Measuring disease-specific health status in a
reliable way becomes essential in times were a wide array of treatment
options are available for PAD patients.
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